IL327379A - תרכובות ושיטות לדילוג על אקסון 50 בניוון שרירים דושן - Google Patents

תרכובות ושיטות לדילוג על אקסון 50 בניוון שרירים דושן

Info

Publication number
IL327379A
IL327379A IL327379A IL32737926A IL327379A IL 327379 A IL327379 A IL 327379A IL 327379 A IL327379 A IL 327379A IL 32737926 A IL32737926 A IL 32737926A IL 327379 A IL327379 A IL 327379A
Authority
IL
Israel
Prior art keywords
compounds
methods
muscular dystrophy
duchenne muscular
skipping exon
Prior art date
Application number
IL327379A
Other languages
English (en)
Original Assignee
Entrada Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Entrada Therapeutics Inc filed Critical Entrada Therapeutics Inc
Publication of IL327379A publication Critical patent/IL327379A/he

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/32—Chemical structure of the sugar
    • C12N2310/323—Chemical structure of the sugar modified ring structure
    • C12N2310/3233—Morpholino-type ring
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/35—Nature of the modification
    • C12N2310/351—Conjugate
    • C12N2310/3513—Protein; Peptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2320/00—Applications; Uses
    • C12N2320/30—Special therapeutic applications
    • C12N2320/32—Special delivery means, e.g. tissue-specific
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2320/00—Applications; Uses
    • C12N2320/30—Special therapeutic applications
    • C12N2320/33—Alteration of splicing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
IL327379A 2023-09-26 2024-09-25 תרכובות ושיטות לדילוג על אקסון 50 בניוון שרירים דושן IL327379A (he)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202363585311P 2023-09-26 2023-09-26
US202363588115P 2023-10-05 2023-10-05
US202463557125P 2024-02-23 2024-02-23
US202463640506P 2024-04-30 2024-04-30
PCT/US2024/048282 WO2025072246A1 (en) 2023-09-26 2024-09-25 Compounds and methods for skipping exon 50 in duchenne muscular dystrophy

Publications (1)

Publication Number Publication Date
IL327379A true IL327379A (he) 2026-05-01

Family

ID=93100244

Family Applications (1)

Application Number Title Priority Date Filing Date
IL327379A IL327379A (he) 2023-09-26 2024-09-25 תרכובות ושיטות לדילוג על אקסון 50 בניוון שרירים דושן

Country Status (3)

Country Link
AU (1) AU2024348141A1 (he)
IL (1) IL327379A (he)
WO (1) WO2025072246A1 (he)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20250325693A1 (en) * 2024-04-03 2025-10-23 Avidity Biosciences, Inc. Antibody-oligonucleotide conjugate compositions and methods of inducing dmd exon 50 skipping

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3756313B2 (ja) 1997-03-07 2006-03-15 武 今西 新規ビシクロヌクレオシド及びオリゴヌクレオチド類縁体
CA2303299C (en) 1997-09-12 2016-02-23 Exiqon A/S Oligonucleotide analogues
JP2002535247A (ja) 1998-11-26 2002-10-22 ペンタファルム アクチェンゲゼルシャフト 輸送系複合体
CA2392490A1 (en) 1999-11-24 2001-05-31 Mcs Micro Carrier Systems Gmbh Polypeptides comprising multimers of nuclear localization signals or of protein transduction domains and their use for transferring molecules into cells
JP4387669B2 (ja) 2000-10-13 2009-12-16 ザイジェン エス.アー. 新規なトランスポーターペプチド配列による生物学的エフェクターの細胞内送達
US7033597B2 (en) 2000-10-13 2006-04-25 Université de Lausanne Intracellular delivery of biological effectors
CN105779453A (zh) * 2008-10-24 2016-07-20 萨雷普塔治疗公司 用于dmd的多外显子跳跃组合物
US10815276B2 (en) 2014-05-21 2020-10-27 Entrada Therapeutics, Inc. Cell penetrating peptides and methods of making and using thereof
HUE045872T2 (hu) 2014-05-21 2020-01-28 Entrada Therapeutics Inc Sejteket penetráló peptidek és ezek elõállítására és alkalmazására szolgáló eljárások
WO2017062835A2 (en) * 2015-10-09 2017-04-13 Sarepta Therapeutics, Inc. Compositions and methods for treating duchenne muscular dystrophy and related disorders
GB201711809D0 (en) 2017-07-21 2017-09-06 Governors Of The Univ Of Alberta Antisense oligonucleotide
MA50269A (fr) * 2017-09-22 2020-07-29 Avidity Biosciences Inc Compositions d'acides nucléiques-polypeptides et méthodes d'induction de saut d'exon
EP4706689A2 (en) 2019-12-19 2026-03-11 Entrada Therapeutics, Inc. Compositions for delivery of antisense compounds
US20250243244A1 (en) 2021-03-31 2025-07-31 Entrada Therapeutics, Inc. Cyclic cell penetrating peptides
AU2022271873A1 (en) 2021-05-10 2024-01-04 Entrada Therapeutics, Inc. Compositions and methods for intracellular therapeutics
GEAP202416440A (en) * 2021-06-23 2024-04-25 Entrada Therapeutics Inc Antisense compounds and methods for targeting cug repeats
US20240390508A1 (en) * 2021-08-21 2024-11-28 Takeda Pharmaceutical Company Limited Human transferrin receptor binding peptide-drug conjugate
EP4395829A1 (en) * 2021-09-01 2024-07-10 Entrada Therapeutics, Inc. Compounds and methods for skipping exon 44 in duchenne muscular dystrophy
JP2024532465A (ja) * 2021-09-01 2024-09-05 エントラーダ セラピューティクス,インコーポレイティド デュシェンヌ型筋ジストロフィーにおいてエクソン45をスキッピングするための組成物及び方法
US20230312653A1 (en) 2022-03-31 2023-10-05 Entrada Therapeutics, Inc. Cyclic cell penetrating peptides

Also Published As

Publication number Publication date
AU2024348141A1 (en) 2026-05-14
WO2025072246A9 (en) 2025-05-08
WO2025072246A1 (en) 2025-04-03

Similar Documents

Publication Publication Date Title
IL311138A (he) הרכבים ושיטות לדילוג על אקסון 45 בניוון שרירים דושן
IL282772B1 (he) שיטה לדילוג יעיל של אקסון (44) בניוון שרירים של דושן ואמצעים נלווים
IL212508A0 (en) Methods and means for efficient skipping of exon 45 in duchenne muscular dystrophy pre-mrna
AU2024348141A1 (en) Compounds and methods for skipping exon 50 in duchenne muscular dystrophy
ZA200600948B (en) Method and apparatus for electrowinning copper using the ferrous/ferric anode reaction
TWI318273B (en) Robot with at least one conductor guiding apparatus
GB0715476D0 (en) Lockable slide hammer and gripping apparatus
EP1804667A4 (en) METHOD AND DEVICE FOR REDUCING METALITY FACTORS IN COMPUTER TOMOGRAPHY
GB0707171D0 (en) Method and apparatus for analyzing and editing ECG morphology and time series
GB0518696D0 (en) Fastener feed method and apparatus
AU2003288583A8 (en) Apparatus for processing an object with high position accurancy
CA3305869A1 (en) Compounds and methods for skipping exon 50 in duchenne muscular dystrophy
HK40108805A (en) Compounds and methods for skipping exon 44 in duchenne muscular dystrophy
HK40108806A (en) Compositions and methods for skipping exon 45 in duchenne muscular dystrophy
MY142270A (en) New process for the synthesis of (7-methoxy-1-naphthyl)acetonitrile and application in the synthesis of agomelatine
AU2003282942A8 (en) Method and apparatus for channel amplitude estimation and interference vector construction
EP2423622A3 (de) Vorrichtung zum Befestigen einer Tragschiene
EP2364819A3 (en) Apparatus for cleaning and organizing fasteners used in dynamoelectric machine
AU2003291466A8 (en) Apparatus and method for detecting ntsc co-channel interference
AU2003259106A8 (en) Method and apparatus for receiving product notices
GB0911649D0 (en) Apparatus and method for sharing and reuse of structured knowledge artifacts
EP1851164A4 (en) METHOD AND APPARATUS FOR A REMOVABLE AGITATOR MOTOR WITH FACADE ACCESS
EP1644970A4 (en) ELECTROLYTIC PROCESSING APPARATUS AND ELECTROLYTIC PROCESSING METHOD
KR101670186B1 (ko) 시청각 교육용 칠판
CN205153839U (zh) 尺寸便于调节的铝制窗